Shanghai Pharmaceuticals Holding Co Ltd (601607 SHG) stock market data APIs
¥17.796
0.04(0.2%)
as of December 31, 2025
Try our APIs with
free plan!
Shanghai Pharmaceuticals Holding Co Ltd Financial Data Overview
Price chart is built with
Anychart
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Prev. Close
17.796
Open
17.8141
High
17.8571
Low
17.6838
52 wk Range
17.28-21.2
Market Cap
66 231 M
P/E Ratio
11.6732
Shares Outstanding
2 789 M
Revenue
280 694 M
EPS
0.19
Beta
0.343
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Shanghai Pharmaceuticals Holding Co Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shanghai Pharmaceuticals Holding Co Ltd data using free add-ons & libraries
Get Shanghai Pharmaceuticals Holding Co Ltd Fundamental Data
Shanghai Pharmaceuticals Holding Co Ltd Fundamental data includes:
- Net Revenue: 280 694 M
- EBITDA: 9 459 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 0.33
Get Shanghai Pharmaceuticals Holding Co Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shanghai Pharmaceuticals Holding Co Ltd News
New
HUTCHMED to Divest 45% Equity Stake in Shanghai Hutchison Pharmaceuticals for $608 Million
HUTCHMED (HCM) said Wednesday it has agreed to sell a 45% equity interest in Shanghai Hutchison Phar PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture
HUTCHMED (China) Limited — HUTCHMED continues to deliver on its strategy outlined in November 2022 to create value, prioritize its portfolio and bring innovative medicines to patients globally �...
aTyr Pharma Announces First Quarter 2022 Results and Provides Corporate Update
aTyr Pharma, Inc. Company to present clinical data for efzofitimod (ATYR1923) in pulmonary sarcoidosis at upcoming American Thoracic Society International Conference in May. Planned registrational s...
West China Hospital's COVID-19 vaccine candidate enters mid-stage human trial
BEIJING, Nov 17 (Reuters) - An experimental coronavirus vaccine developed by West China Hospital has entered a mid-stage human test, authorities of China's southwestern province of Sichuan said on Tue...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
